Catalent Trims Annual Projection Amidst Operational Hurdles
Pharmaceutical industry giant, Catalent, has recently announced a significant cut in its annual forecast, primarily due to a series of operational challenges. The company, which is a renowned global provider of advanced delivery technologies and development solutions for drugs, biologics, gene therapies, and consumer health products, has downgraded its predicted adjusted net income for the…